Power Hour Push: Biotech, Blockchain, and Breakouts Set to Run into Afterhours
DENVER, Colo., Aug 22, 2025 (247marketnews.com)- As markets head into the final hour of trading, today’s action is marked by bold catalysts and here are the names making noise into the close:
Incannex NASDAQ:IXHL) surged this morning after unveiling a $20 million share repurchase program, reinforcing confidence in the company’s pipeline and undervalued stock price. CEO Joel Latham stated the move reflects belief in the company’s strategic direction and clinical progress. With late-stage trials across multiple indications and a lean cap table, Incannex may remain active afterhours as institutional investors take note.
LIXTE (NASDAQ:LIXT) continues to climb, driven by enthusiasm for LB-100, its lead PP2A inhibitor being tested with Roche’s (OTCQX:RHHBY) atezolizumab and GSK’s (NYSE:GSK) dostarlimab. The compound’s potential to convert non-responsive tumors into immunotherapy-sensitive cancers is gaining traction.
Opendoor (NASDAQ:OPEN) is trending higher in late trading after strong housing market data and better-than-expected regional price resilience. While not reporting earnings today, sentiment is shifting as investors reevaluate Opendoor’s real estate inventory strategy and potential margin recovery in H2 2025. With Fed rate cut expectations also rising, OPEN is a name to watch into the close.
Cybersecurity microcap Cycurion (NASDAQ:CYCR) is quietly making waves today, trading higher on increasing chatter around potential federal contract wins tied to national infrastructure and defense systems. As digital threat response becomes a core element of critical infrastructure, including portable reactor platforms, CYCR is riding both a narrative and technical breakout.
Providence Service (NASDAQ:PRSC), a legacy name in healthcare logistics, is under watch after Modivcare (NASDAQ:MODV), its former subsidiary, filed for Chapter 11. Traders are eyeing PRSC as a backdoor play on post-restructuring value recovery and realignment in the non-emergency medical transportation space. No direct exposure to MODV’s current balance sheet issues makes PRSC an intriguing speculative name.
PMGC (NASDAQ:PMGC) is seeing light-volume interest but remains on watch for those tracking U.S. industrial and defense-related mobile energy infrastructure. The company has ties to advanced construction materials and field operations, and recent government spending bills may bring this microcap under greater visibility.
Nexalin (NASDAQ:NXL) is turning heads today after recent clinical updates on its neurostimulation platform for mental health and addiction. While no new release dropped today, the chart shows signs of accumulation. With national focus on brain health intensifying, especially for veterans and high-risk populations, Nexalin could be positioning for a breakout moment.
Liminatus (NASDAQ:LMNT) is holding gains into the afternoon following strong interest in its CAR-T pipeline for solid tumors. Traders are watching closely after rumors of potential partnership discussions with larger oncology players. Though unconfirmed, volume spikes and speculative chatter suggest afterhours volatility is possible.
China-based Airnet (NASDAQ:ANTE) is flashing green as tech stocks rally and travel tech sees renewed attention. With its pivot toward blockchain-enabled digital advertising for the aviation industry, ANTE’s hybrid model is gaining curiosity, especially among small-cap Asia-focused funds.
Cognition (NASDAQ:CGTX) remains volatile following a recent pullback, but with Alzheimer’s diagnostics and treatment gaining renewed policy and investor focus, traders are revisiting this name. As a participant in targeted neurodegenerative trials, Cognition is seen as a value biotech in a crowded space, and dip buyers are starting to step back in.
ALT5 Sigma (NASDAQ:ALTS) is generating chatter across message boards after multiple media reports suggested digital asset tokenization partnerships with real-world infrastructure projects could be announced in Q4.
ImmunoPrecise (NASDAQ:IPA) is staging a late-day recovery following this week’s earnings report. While results were mixed, management highlighted strong advances in its AI-driven antibody discovery platforms. With strategic partnerships and pharma collaborations growing, IPA is a name to monitor into afterhours for any updates or volume signals.
For additional 247marketnews.com and LIXT disclosure https://247marketnews.com/lixte-biotechnology/
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com